IP Library › Granted Patent US 11,034,780
Granted Patent B2
US 11,034,780 · App. 16/230,180 · Granted Jun 15, 2021

1,3-dipolar compound bearing an imidazole functional group

Inventors: Oleg Ugolnikov (Clermont-Ferrand, FR); Sergey Ivanov (Clermont-Ferrand, FR); Claire Rannoux (Clermont-Ferrand, FR); Anne-Frédérique Salit (Clermont-Ferrand, FR); Sophie Gander (Clermont-Ferrand, FR); Anne-Lise Thuilliez (Clermont-Ferrand, FR)
Assignee: COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
C08F8/30C07D233/61C08C19/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,034,780
App. No.
16/230,180
Granted
Jun 15, 2021
Kind
B2
Abstract

In a 1,3-dipolar compound of formula Q-A-B, Q comprises a dipole containing at least and preferably one nitrogen atom, A, which is preferably divalent, is an atom or a group of atoms connecting Q to B, and B comprises an imidazole ring. An unsaturated polymer modified by grafting the 1,3-dipolar compound is also disclosed.

Claims (15)

1. A 1,3-dipolar compound of formula (I):

Q-A-B  (I)

wherein Q consists of the unit corresponding to the formula (III)

in which four of the five symbols R 1 to R 5 , which are identical or different, are each an atom or a group of atoms and the fifth of the five symbols R 1 to R 5 denotes a direct attachment to A, where R 1 and R 5 are both other than H,

wherein A is an alkylene group containing from 1 to 20 carbon atoms or an arylene group containing from 6 to 20 carbon atoms connecting Q to B, and

wherein B consists of a ring of formula (II):

wherein Z and Y are each a hydrogen atom, R represents an atom or a group of atoms, and R′ denotes a direct attachment to A.

2. The 1,3-dipolar compound of claim 1 , wherein R represents a hydrogen atom or a carbon-based group containing from 1 to 20 carbon atoms which can contain at least one heteroatom.

3. The 1,3-dipolar compound of claim 1 , wherein R is an aliphatic group.

4. The 1,3-dipolar compound of claim 1 , wherein R is an alkyl group which contains from 1 to 12 carbon atoms.

5. The 1,3-dipolar compound of claim 1 , wherein R is a methyl.

6. The 1,3-dipolar compound of claim 1 , wherein four of the five symbols R 1 to R 5 , which are identical or different, are each an aliphatic group or an aromatic group.

7. The 1,3-dipolar compound of claim 1 , wherein R 1 , R 3 and R 5 are each an alkyl group of 1 to 6 carbon atoms.

8. The 1,3-dipolar compound of claim 1 , wherein R 1 , R 3 and R 5 are each a methyl or ethyl.

9. The 1,3-dipolar compound of claim 1 , wherein the 1,3-dipolar compound is 2,4,6-trimethyl-3-((2-methyl-1H-imidazol-1-yl)methyl)benzonitrile oxide or 2,4,6-triethyl-3-((2-methyl-1H-imidazol-1-yl)methyl)benzonitrile oxide.

Priority Claims (1)
FR 1360413 · Oct 25, 2013 · national
Continuity (2)
Division 15031337
Related Publication 20190119412A1 · Apr 25, 2019
Cited By (2)
US 12,600,171 US 12,679,935